Cleared Traditional

K251416 - UltraSight Guidance (FDA 510(k) Clearance)

Dec 2025
Decision
224d
Days
Class 2
Risk

K251416 is an FDA 510(k) clearance for the UltraSight Guidance. This device is classified as a Image Acquisition And/or Optimization Guided By Artificial Intelligence (Class II - Special Controls, product code QJU).

Submitted by Ultrasight , Ltd. (Ness Ziona, IL). The FDA issued a Cleared decision on December 17, 2025, 224 days after receiving the submission on May 7, 2025.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2100. A Radiological Acquisition And/or Optimization Guidance System Is A Device That Is Intended To Aid In The Acquisition And/or Optimization Of Images And/or Diagnostic Signals. The Device Interfaces With The Acquisition System, Analyzes Its Output, And Provides Guidance And/or Feedback To The Operator For Improving Image And/or Signal Quality..

Submission Details

510(k) Number K251416 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 2025
Decision Date December 17, 2025
Days to Decision 224 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code QJU - Image Acquisition And/or Optimization Guided By Artificial Intelligence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2100
Definition A Radiological Acquisition And/or Optimization Guidance System Is A Device That Is Intended To Aid In The Acquisition And/or Optimization Of Images And/or Diagnostic Signals. The Device Interfaces With The Acquisition System, Analyzes Its Output, And Provides Guidance And/or Feedback To The Operator For Improving Image And/or Signal Quality.